| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.000864859564133848 | 0.40418792 |
| NSC 639505 | Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride | 0.000930692338491031 | 0.40616811 |
| NSC 743853 | Null | 0.00115358042961468 | 0.37743345 |
| NSC 750743 | (E)-3-(6-(thiophen-2-yl)imidazo[2,1-b]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | 0.00115358042961468 | 0.12542674 |
| NSC 31709 | Quinolinium, 2-[2-(2,5-dimethyl-1-pentyl-1H-pyrrol-3-yl)ethenyl]-1,6-dimethyl-, chloride | 0.00115358042961469 | 0.39798194 |
| NSC 340847 | 4-Selenazolecarboxamide, 2-.beta.-D-ribofuranosyl- | 0.00115358042961469 | 0.51066817 |
| NSC 620277 | 4-N,N-bis-2'-cyanoethylaminobenzylidene-4-fluoro aniline | 0.00115358042961469 | 0.53006104 |
| NSC 624659 | ANTINEOPLASTIC-624659 | 0.00115358042961469 | 0.4550683 |
| NSC 625505 | Null | 0.00115358042961469 | 0.52456049 |
| NSC 627748 | Null | 0.00115358042961469 | 0.36532752 |